# Voestalpine (Brazil)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/voestalpine-brazil/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 25 |
| Citations | 4,097 |
| City | São Paulo |
| Country | BR |
| Description | Voestalpine (Brazil) is a research organisation in São Paulo, BR. OpenAlex records 403 works and 4,097 citations for it. 122 researchers list it as their most recent affiliation. |
| Homepage | http://www.voestalpine.com/group/pt/ |
| OpenAlex ID | https://openalex.org/I4210097305 |
| Researchers | 122 |
| ROR ID | https://ror.org/00tgp6q68 |
| Type | company |
| Works | 403 |

## University papers

- [ERS clinical practice guidelines on treatment of sarcoidosis](https://scholariq.org/papers/ers-clinical-practice-guidelines-on-treatment-of-sarcoidosis/)
- [A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19](https://scholariq.org/papers/a-rush-to-judgment-rapid-reporting-and-dissemination-of-results-and-its/)
- [Linking Alzheimer's disease to insulin resistance: the FoxO response to oxidative stress](https://scholariq.org/papers/linking-alzheimer-s-disease-to-insulin-resistance-the-foxo-response-to-oxidative/)
- [Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment](https://scholariq.org/papers/methotrexate-associated-pneumonitis-and-rheumatoid-arthritis-interstitial-lung/)
- [Low-dose hydralazine prevents fibrosis in a murine model of acute kidney injury–to–chronic kidney disease progression](https://scholariq.org/papers/low-dose-hydralazine-prevents-fibrosis-in-a-murine-model-of-acute-kidney-injury/)
- [Tocilizumab in the treatment of rheumatoid arthritis and beyond](https://scholariq.org/papers/tocilizumab-in-the-treatment-of-rheumatoid-arthritis-and-beyond/)
- [Rheumatologic Manifestations of Sarcoidosis](https://scholariq.org/papers/rheumatologic-manifestations-of-sarcoidosis/)
- [Antirheumatic Disease Therapies for the Treatment of COVID‐19: A Systematic Review and Meta‐Analysis](https://scholariq.org/papers/antirheumatic-disease-therapies-for-the-treatment-of-covid-19-a-systematic/)
- [Management of extrapulmonary sarcoidosis: challenges and solutions](https://scholariq.org/papers/management-of-extrapulmonary-sarcoidosis-challenges-and-solutions/)
- [Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19](https://scholariq.org/papers/swinging-the-pendulum-lessons-learned-from-public-discourse-concerning/)
- [Belimumab for systemic lupus erythematosus – Focus on lupus nephritis](https://scholariq.org/papers/belimumab-for-systemic-lupus-erythematosus-focus-on-lupus-nephritis/)

## University researchers

- [Peter Korsten](https://scholariq.org/researchers/peter-korsten/)

## University top topics

Showing 8 of 23.

- [Autoimmune and Inflammatory Disorders Research](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders-research/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Adolescent and Pediatric Healthcare](https://scholariq.org/topics/adolescent-and-pediatric-healthcare/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Orthopedic Infections and Treatments](https://scholariq.org/topics/orthopedic-infections-and-treatments/)
- [Inflammasome and immune disorders](https://scholariq.org/topics/inflammasome-and-immune-disorders/)
- [Musculoskeletal Disorders and Rehabilitation](https://scholariq.org/topics/musculoskeletal-disorders-and-rehabilitation/)
- [Elbow and Forearm Trauma Treatment](https://scholariq.org/topics/elbow-and-forearm-trauma-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.